Samsung Biologics, a global contract development and manufacturing organization (CDMO), has extended its collaboration with ...

Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services.

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to SOTIO Biotech, a ...

Under the agreement, Ailux Biologics grants UCB a non-exclusive license to leverage XtalFold™ for the discovery and ...

NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services for drug discovery and ...

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• NAYA aiming to ...

NIH Researchers Discover Novel Class of Anti-Malaria Antibodies - New Antibodies Could Lead to Generation of Interventions ...

Shares of Fusion Antibodies plc (LON:FAB – Get Free Report) reached a new 52-week high on Friday . The company traded as high as GBX 10.25 ($0.13) and last traded at GBX 10.23 ($0.13), with a volume ...

New antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody ...

Our services are intended for corporate subscribers and you warrant that the email address ... Jemincare are set to deliver top-line data in the second half of next year and the first half of 2026, ...

RPT904 is being developed to offer patients a potentially improved therapeutic option compared to omalizumab (marketed as Xolair ®), an anti-IgE monoclonal antibody approved for several allergic ...